// App-Quantinova.ai

1139 : Translational control of MYC protein stability as a target of small molecules

Researchers

Presenter

  • Naohiko Ikegaki

Principal Investigators

  • Luqman Baloch

  • Christopher Chu

  • Joshua Lomahan

  • Jamie Harris

  • Bill Chiu

Medical Centers

  • University of Illinios at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mismatch repair deficiency

  • Neuroblastoma

  • Scleroderma

  • Solid malignancies

Biomarkers

  • MYCN proto-oncogene, bHLH transcription factor

Drug/Treatment

  • Halofuginone

  • salinomycin

  • AR 12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved